Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

NCT02692105 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Low dose rate prostate brachytherapy
RADIATION: High Dose Rate prostate brachytherapy

Sponsor

British Columbia Cancer Agency